The impact of venetoclax based regimens in the preemptive of measurable residual disease in acute myeloid leukemia
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health
2022-01-01
|
Series: | Blood Science |
Online Access: | http://journals.lww.com/10.1097/BS9.0000000000000101 |